Literature DB >> 8782178

An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio.

G J Barker1, P S Tofts, A Gass.   

Abstract

We demonstrate an interleaved dual spin echo-based sequence for quantitative measurement of Magnetisation Transfer Ratio (MTR) in a clinical environment that overcomes the problems of patient motion between scans faced by noninterleaved methods. The sequence also provides proton density and T2-weighted images, allowing direct comparison among the three contrast regimes. Phantom studies and in vivo measurements on normal controls show the sequence to be robust in normal use. The values of MTR calculated from the sequence are shown to be precise and reproducible enough to allow regional variations to be identified within and between white matter and other brain tissues.

Entities:  

Mesh:

Year:  1996        PMID: 8782178     DOI: 10.1016/0730-725x(96)00019-7

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  24 in total

1.  Scan-rescan variation of measures derived from brain magnetization transfer ratio histograms obtained in healthy volunteers by use of a semi-interleaved magnetization transfer sequence.

Authors:  M Inglese; M A Horsfield; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  MTR variations in normal adult brain structures using balanced steady-state free precession.

Authors:  Meritxell Garcia; Monika Gloor; Oliver Bieri; Stephan G Wetzel; Ernst-Wilhelm Radue; Klaus Scheffler
Journal:  Neuroradiology       Date:  2010-05-18       Impact factor: 2.804

3.  Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter.

Authors:  Klaus Schmierer; Janet R Thavarajah; Shu F An; Sebastian Brandner; David H Miller; Daniel J Tozer
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

4.  A standardised method for measuring magnetisation transfer ratio on MR imagers from different manufacturers--the EuroMT sequence.

Authors:  G J Barker; W G Schreiber; A Gass; J P Ranjeva; A Campi; J H T M van Waesberghe; J-M Franconi; H C Watt; P S Tofts
Journal:  MAGMA       Date:  2005-03-22       Impact factor: 2.310

Review 5.  Functional MRI and CT biomarkers in oncology.

Authors:  J M Winfield; G S Payne; N M deSouza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-13       Impact factor: 9.236

6.  Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life.

Authors:  N C Silver; G J Barker; D G MacManus; P S Tofts; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

7.  HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.

Authors:  Carmen Tur; Sreeram Ramagopalan; Daniel R Altmann; Benedetta Bodini; Mara Cercignani; Zhaleh Khaleeli; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Neurology       Date:  2014-10-08       Impact factor: 9.910

8.  A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Authors:  Benedetta Bodini; Mara Cercignani; Ahmed Toosy; Nicola De Stefano; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2013-04-24       Impact factor: 5.038

9.  Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; R A C Hughes; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

10.  Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Authors:  Gary Price; Mara Cercignani; Elvina M Chu; Thomas R E Barnes; Gareth J Barker; Eileen M Joyce; Maria A Ron
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.